Perception Molecular Diagnostics Hosts This autumn 2025 Earnings Convention Name
Sr. Govt Assistant Gabrielle Woody kicked off Perception Molecular Diagnostics’ Fourth Quarter 2025 earnings name, welcoming individuals and thanking them for becoming a member of the overview of the corporate’s newest outcomes.
Attendees can entry the excellent shareholder letter on the Investor Relations web page at buyers.imdxinc.com. Ready remarks in the course of the name increase on particulars from that letter.
Govt and Analyst Members
Firm leaders current embrace President and CEO Joshua Riggs, Chief Monetary Officer Andrea James, and Chief Science Officer Ekkehard Schutz.
Analysts becoming a member of as panelists are Thomas Flaten from Lake Avenue Capital Markets Analysis Division, Michael Matson from Needham & Firm Analysis Division, and Benjamin Mee from Stephens Inc. Analysis Division.
Q&A with analysts follows the ready feedback.
Protected Harbor Provisions
Officers highlighted forward-looking statements about future occasions, protected underneath the Non-public Securities Litigation Reform Act of 1995 protected harbor. These exclude historic information.
Evaluate current SEC filings like Type 10-Ok and 10-Qs for dangers that would alter outcomes. Statements mirror situations on the time of the decision, with no dedication to updates.
Joshua Riggs, President and CEO, then took the ground.
